TSC1 and TSC2 gene mutations and their implications for treatment in Tuberous Sclerosis Complex: a review
AUTOR(ES)
Rosset, Clévia, Netto, Cristina Brinckmann Oliveira, Ashton-Prolla, Patricia
FONTE
Genet. Mol. Biol.
DATA DE PUBLICAÇÃO
20/02/2017
RESUMO
Abstract Tuberous sclerosis complex is an autosomal dominant disorder characterized by skin manifestations and formation of multiple tumors in different organs, mainly in the central nervous system. Tuberous sclerosis is caused by the mutation of one of two tumor suppressor genes, TSC1 or TSC2. Currently, the development of novel techniques and great advances in high-throughput genetic analysis made mutation screening of the TSC1 and TSC2 genes more widely available. Extensive studies of the TSC1 and TSC2 genes in patients with TSC worldwide have revealed a wide spectrum of mutations. Consequently, the discovery of the underlying genetic defects in TSC has furthered our understanding of this complex genetic disorder, and genotype-phenotype correlations are becoming possible, although there are still only a few clearly established correlations. This review focuses on the main symptoms and genetic alterations described in TSC patients from 13 countries in three continents, as well as on genotype-phenotype correlations established to date. The determination of genotype-phenotype correlations may contribute to the establishment of successful personalized treatment for TSC.
Documentos Relacionados
- Mutations in the tuberous sclerosis complex gene TSC2 are a cause of sporadic pulmonary lymphangioleiomyomatosis
- Mutations in the TSC1 gene account for a minority of patients with tuberous sclerosis.
- TSC1 and TSC2 tumor suppressors antagonize insulin signaling in cell growth
- Identification of a nonsense mutation at the 5' end of the TSC2 gene in a family with a presumptive diagnosis of tuberous sclerosis complex.
- Tuberous sclerosis complex: review based on new diagnostic criteria